The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Lyra Therapeutics Inc shares valued at $74,095 were purchased by Waksal Harlan on Nov 10 ’23. At $2.96 per share, Waksal Harlan acquired 25,000 shares. The insider’s holdings grew to 261,966 shares worth approximately $1.38 million following the completion of this transaction.
Also, PERCEPTIVE ADVISORS LLC purchased 3,610,832 shares, netting a total of over 8,999,999 in proceeds. Following the buying of shares at $2.49 each, the insider now holds 11,469,117 shares.
Before that, ANDERSON EDWARD T had added 1,805,416 shares to its account. In a trade valued at $4,387,161, the Director bought Lyra Therapeutics Inc shares for $2.43 each. Upon closing the transaction, the insider’s holdings increased to 1,805,416 shares, worth approximately $13.24 million.
Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of May 24, 2022, Cantor Fitzgerald has initiated its “an Overweight” rating for LYRA. Earlier on May 26, 2020, William Blair initiated its rating. Their recommendation was “an Outperform” for LYRA stock.
Analyzing LYRA Stock Performance
During the last five days, there has been a surge of approximately 0.38%. Over the course of the year, Lyra Therapeutics Inc shares have jumped approximately 0.19%. Shares of the company reached a 52-week high of $6.79 on 03/27/24 and a 52-week low of $4.19 on 01/24/24. A 50-day SMA is recorded $5.53, while a 200-day SMA reached $4.32. Nevertheless, trading volume fell to 0.47 million shares from 0.26 million shares the previous day.
Support And Resistance Levels for Lyra Therapeutics Inc (LYRA)
According to the 24-hour chart, there is a support level at 4.95, which, if violated, would cause prices to drop to 4.65. In the upper region, resistance lies at 5.60. The next price resistance is at 5.95. RSI (Relative Strength Index) is 48.51 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.14, which suggests the price will decrease in the coming days. Percent R is at 47.71%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
